Literature DB >> 29152027

Design considerations for open-well microfluidic platforms for hypoxic cell studies.

Matthew B Byrne, Matthew T Leslie, Heeral S Patel1, H Rex Gaskins, Paul J A Kenis.   

Abstract

Regions of hypoxia are common in solid tumors and are associated with enhanced malignancy, metastasis, and chemo/radio resistance. Real-time hypoxic cellular experimentation is challenging due to the constant need for oxygen control. Most microfluidic platforms developed thus far for hypoxic cell studies are burdened by complex design parameters and are difficult to use for uninitiated investigators. However, open-well microfluidic platforms enable short and long term hypoxic cell studies with an ease of use workflow. Specifically, open-well platforms enable manipulation and addition of cells, media, and reagents using a micropipette for hypoxic cell studies in tunable dissolved oxygen concentrations as low 0.3 mg/l. We analyzed design considerations for open-well microfluidic platforms such as media height, membrane thickness, and impermeable barriers to determine their effects on the amount of dissolved oxygen within the platform. The oxygen concentration was determined by experimental measurements and computational simulations. To examine cell behavior under controlled oxygen conditions, hypoxia-induced changes to hypoxia inducible factor activity and the mitochondrial redox environment were studied. A fluorescent reporter construct was used to monitor the stabilization of hypoxia inducible factors 1α and 2α throughout chronic hypoxia. Reporter construct fluorescence intensity inversely correlated with dissolved oxygen in the medium, as expected. Additionally, the glutathione redox poise of the mitochondrial matrix in living cancer cells was monitored throughout acute hypoxia with a genetically encoded redox probe and was observed to undergo a reductive response to hypoxia. Overall, these studies validate an easy to use open-well platform suitable for studying complex cell behaviors in hypoxia.

Entities:  

Year:  2017        PMID: 29152027      PMCID: PMC5659862          DOI: 10.1063/1.4998579

Source DB:  PubMed          Journal:  Biomicrofluidics        ISSN: 1932-1058            Impact factor:   2.800


  54 in total

Review 1.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

2.  Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators.

Authors:  Colette T Dooley; Timothy M Dore; George T Hanson; W Coyt Jackson; S James Remington; Roger Y Tsien
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

3.  Design and development of microbioreactors for long-term cell culture in controlled oxygen microenvironments.

Authors:  Hasan E Abaci; Raghavendra Devendra; Quinton Smith; Sharon Gerecht; German Drazer
Journal:  Biomed Microdevices       Date:  2012-02       Impact factor: 2.838

Review 4.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

5.  Microfluidic platform for the study of intercellular communication via soluble factor-cell and cell-cell paracrine signaling.

Authors:  Matthew B Byrne; Lisa Trump; Amit V Desai; Lawrence B Schook; H Rex Gaskins; Paul J A Kenis
Journal:  Biomicrofluidics       Date:  2014-07-10       Impact factor: 2.800

Review 6.  Oxygen control with microfluidics.

Authors:  Martin D Brennan; Megan L Rexius-Hall; Laura Jane Elgass; David T Eddington
Journal:  Lab Chip       Date:  2014-11-21       Impact factor: 6.799

7.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing.

Authors:  Robert D Guzy; Beatrice Hoyos; Emmanuel Robin; Hong Chen; Liping Liu; Kyle D Mansfield; M Celeste Simon; Ulrich Hammerling; Paul T Schumacker
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

8.  Fine temporal control of the medium gas content and acidity and on-chip generation of series of oxygen concentrations for cell cultures.

Authors:  Mark Polinkovsky; Edgar Gutierrez; Andre Levchenko; Alex Groisman
Journal:  Lab Chip       Date:  2009-02-17       Impact factor: 6.799

9.  Hard top soft bottom microfluidic devices for cell culture and chemical analysis.

Authors:  Geeta Mehta; Jay Lee; Wansik Cha; Yi-Chung Tung; Jennifer J Linderman; Shuichi Takayama
Journal:  Anal Chem       Date:  2009-05-15       Impact factor: 6.986

10.  Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells.

Authors:  Annie Y Chi; Gregory B Waypa; Paul T Mungai; Paul T Schumacker
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

View more
  4 in total

1.  Open microfluidic coculture reveals paracrine signaling from human kidney epithelial cells promotes kidney specificity of endothelial cells.

Authors:  Tianzi Zhang; Daniel Lih; Ryan J Nagao; Jun Xue; Erwin Berthier; Jonathan Himmelfarb; Ying Zheng; Ashleigh B Theberge
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-11

2.  Generating linear oxygen gradients across 3D cell cultures with block-layered oxygen controlled chips (BLOCCs).

Authors:  Matthew W Boyce; William C Simke; Rachael M Kenney; Matthew R Lockett
Journal:  Anal Methods       Date:  2019-11-26       Impact factor: 2.896

Review 3.  Genetically Encoded Tools for Research of Cell Signaling and Metabolism under Brain Hypoxia.

Authors:  Alexander I Kostyuk; Aleksandra D Kokova; Oleg V Podgorny; Ilya V Kelmanson; Elena S Fetisova; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Antioxidants (Basel)       Date:  2020-06-11

4.  Open multi-culture platform for simple and flexible study of multi-cell type interactions.

Authors:  Yasmín R Álvarez-García; Karla P Ramos-Cruz; Reinaldo J Agostini-Infanzón; Loren E Stallcop; David J Beebe; Jay W Warrick; Maribella Domenech
Journal:  Lab Chip       Date:  2018-10-09       Impact factor: 6.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.